Arjo AB (publ)
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and pr… Read more
Arjo AB (publ) (ARRJF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.080x
Based on the latest financial reports, Arjo AB (publ) (ARRJF) has a cash flow conversion efficiency ratio of 0.080x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($600.00 Million) by net assets ($7.46 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Arjo AB (publ) - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Arjo AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Arjo AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Arjo AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mcmillan Shakespeare Ltd
AU:MMS
|
-0.294x |
|
Vgi Partners Global Investments Ltd
AU:VG1
|
0.143x |
|
Mutares SE & Co. KGaA
XETRA:MUX
|
-0.145x |
|
Ingram Micro Holding Corporation
NYSE:INGM
|
0.367x |
|
Maitri Health Technologies Corp
PINK:MHTCF
|
0.000x |
|
JLGRF
PINK:JLGRF
|
N/A |
|
PayPoint plc
OTCGREY:PYPTF
|
0.327x |
|
Dril-Quip Inc
F:DQU
|
-0.011x |
Annual Cash Flow Conversion Efficiency for Arjo AB (publ) (2014–2025)
The table below shows the annual cash flow conversion efficiency of Arjo AB (publ) from 2014 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $7.46 Billion | $1.44 Billion | 0.192x | +5.84% |
| 2024-12-31 | $8.34 Billion | $1.52 Billion | 0.182x | -33.11% |
| 2023-12-31 | $7.58 Billion | $2.06 Billion | 0.272x | +126.49% |
| 2022-12-31 | $7.62 Billion | $915.00 Million | 0.120x | -52.35% |
| 2021-12-31 | $6.88 Billion | $1.73 Billion | 0.252x | -37.45% |
| 2020-12-31 | $5.63 Billion | $2.27 Billion | 0.403x | +90.20% |
| 2019-12-31 | $5.91 Billion | $1.25 Billion | 0.212x | +15.93% |
| 2018-12-31 | $5.43 Billion | $991.00 Million | 0.183x | +61.98% |
| 2017-12-31 | $5.07 Billion | $572.00 Million | 0.113x | +30.74% |
| 2016-12-31 | $10.66 Billion | $919.00 Million | 0.086x | +8.73% |
| 2015-12-31 | $10.23 Billion | $811.00 Million | 0.079x | -12.33% |
| 2014-12-31 | $10.60 Billion | $959.00 Million | 0.090x | -- |